84 related articles for article (PubMed ID: 2317010)
1. Immunological studies in tropical spastic paraparesis.
Jacobson S; Gupta A; Mattson D; Mingioli E; McFarlin DE
Ann Neurol; 1990 Feb; 27(2):149-56. PubMed ID: 2317010
[TBL] [Abstract][Full Text] [Related]
2. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
3. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
Azimi N; Jacobson S; Leist T; Waldmann TA
J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
[TBL] [Abstract][Full Text] [Related]
4. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
7. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR
Virology; 1996 Mar; 217(1):139-46. PubMed ID: 8599198
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
[TBL] [Abstract][Full Text] [Related]
9. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
10. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
11. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
[TBL] [Abstract][Full Text] [Related]
12. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Biddison WE; Kubota R; Kawanishi T; Taub DD; Cruikshank WW; Center DM; Connor EW; Utz U; Jacobson S
J Immunol; 1997 Aug; 159(4):2018-25. PubMed ID: 9257869
[TBL] [Abstract][Full Text] [Related]
13. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
[TBL] [Abstract][Full Text] [Related]
14. Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis.
Jacobson S; Raine CS; Mingioli ES; McFarlin DE
Nature; 1988 Feb; 331(6156):540-3. PubMed ID: 2829028
[TBL] [Abstract][Full Text] [Related]
15. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
16. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells.
Cavrois M; Gessain A; Gout O; Wain-Hobson S; Wattel E
J Infect Dis; 2000 Oct; 182(4):1044-50. PubMed ID: 10979898
[TBL] [Abstract][Full Text] [Related]
17. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
[TBL] [Abstract][Full Text] [Related]
18. Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy.
Hayashi D; Kubota R; Takenouchi N; Tanaka Y; Hirano R; Takashima H; Osame M; Izumo S; Arimura K
J Neuroimmunol; 2008 Aug; 200(1-2):115-24. PubMed ID: 18639344
[TBL] [Abstract][Full Text] [Related]
19. Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan.
Nishimura M; Jacobson S; Uchiyama T; Ohta M; Saida T
Mult Scler; 1996 Feb; 1(4):200-3. PubMed ID: 9345434
[TBL] [Abstract][Full Text] [Related]
20. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
